| Name |
Zoladex 3,6 mg implantat |
| Marketing Authorisation Number |
HR-H-247320153 |
| Active Substance |
goserelinacetat |
| Composition |
implantat u napunjenoj štrcaljki sadrži 3,6 mg goserelina u obliku goserelinacetata dispergiranog u biološki razgradivom matriksu kopolimera |
| Pharmaceutical Form |
implantat |
| Manufacturer |
AstraZeneca AB, Sodertalje, Švedska |
| Marketing Authorisation Holder |
AstraZeneca d.o.o., Ulica Vjekoslava Heinzela 70, Zagreb, Hrvatska |
| Marketing Authorisation Date |
27.11.2015 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/14-02/265 |
| Registration Number |
381-12-01/30-15-15 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ograničeni recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
L02AE03 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
